General MedicationsINJECTIONStandard
HEMABATE
CARBOPROST TROMETHAMINE
Standard Dose
EQ 0.25MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview HEMABATE is listed in Drugs@FDA under application 017989 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CARBOPROST TROMETHAMINE Form and strength INJECTABLE;INJECTION - EQ 0.25MG BASE/ML Sponsor PFIZER Submission history Latest submission status date: 2015-06-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview HEMABATE is listed in Drugs@FDA under application 017989 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CARBOPROST TROMETHAMINE Form and strength INJECTABLE;INJECTION - EQ 0.25MG BASE/ML Sponsor PFIZER Submission history Latest submission status date: 2015-06-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.